Tissue Engineering Market by Type (Biologically Derived Scaffold, Synthetic Scaffold), Material (Biomimetic Material, Composite Material, Nano-Composite Material), Indication, Application - Global Forecast 2023-2030
The Tissue Engineering Market size was estimated at USD 36.34 billion in 2022 and expected to reach USD 43.13 billion in 2023, at a CAGR 18.80% to reach USD 144.28 billion by 2030.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Tissue Engineering Market.
- Based on Type, market is studied across Biologically Derived Scaffold and Synthetic Scaffold. The Biologically Derived Scaffold is further studied across Alginates, Celluloses, and Zein. The Synthetic Scaffold is further studied across Poly-Lactic-Co-Glycolic Acid (PLGA), Polycaprolactone (PCL), and Polylactic Acid (PLA). The Biologically Derived Scaffold is projected to witness significant market share during forecast period.
- Based on Material, market is studied across Biomimetic Material, Composite Material, Nano-Composite Material, and Nano-Fibrous Material. The Composite Material is projected to witness significant market share during forecast period.
- Based on Indication, market is studied across Cancer, Cardiology, Cord Blood & Cell Banking, Dental, Gastrointestinal & Gynaecology, Neurology, Organ Replacement, Transplants & Ophthalmology, Orthopedics, Musculoskeletal & Spine, Skin & Integumentary, and Urology. The Urology is projected to witness significant market share during forecast period.
- Based on Application, market is studied across Biomaterials, Biomedical Engineering, and Regenerative Medicine. The Regenerative Medicine is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Tissue Engineering Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Tissue Engineering Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Tissue Engineering Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aspect Biosystems Ltd., B. Braun SE, Baxter International Inc., Bayer AG, Becton, Dickinson and Company, Cook Group Incorporated, Corning Incorporated, CTIBiotech, Frequency Therapeutics, Gel4Med, General Electric Company, Humacyte, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Miromatrix Medical, Inc., Modern Meadow, Novartis AG, Organogenesis Inc., Organovo Holdings, Inc., Pfizer Inc., Prellis Biologics, ReproCell Inc., Smith & Nephew PLC, Stryker Corporation, Tissue Regeneration Systems Inc., Vericel Corporation, and Zimmer Biomet Holdings, Inc..
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Tissue Engineering Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Tissue Engineering Market?
- What is the competitive strategic window for identifying opportunities in the Tissue Engineering Market?
- What are the latest technology trends and regulatory frameworks in the Tissue Engineering Market?
- What is the market share of the leading vendors in the Tissue Engineering Market?
- Which modes and strategic moves are suitable for entering the Tissue Engineering Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Tissue Engineering Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Potential need for tissue engineering procedures in treating irreversible damage of tissues
- 5.1.1.2. Need for effective regenerative treatments owing to a rise in kidney and lifestyle related disorders
- 5.1.1.3. Growing use of biogenic nanoparticles for advanced tissue engineering applications
- 5.1.2. Restraints
- 5.1.2.1. Lack of suitable biomaterials and techniques for capturing appropriate physiological architectures
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in the field of 3D tissue engineering
- 5.1.3.2. Surging government support for tissue engineering research projects
- 5.1.4. Challenges
- 5.1.4.1. Stringent government regulations associated with tissue engineering
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Tissue Engineering Market, by Type
- 6.1. Introduction
- 6.2. Biologically Derived Scaffold
- 6.3.1. Alginates
- 6.3.2. Celluloses
- 6.3.3. Zein
- 6.3. Synthetic Scaffold
- 6.4.1. Poly-Lactic-Co-Glycolic Acid (PLGA)
- 6.4.2. Polycaprolactone (PCL)
- 6.4.3. Polylactic Acid (PLA)
- 7. Tissue Engineering Market, by Material
- 7.1. Introduction
- 7.2. Biomimetic Material
- 7.3. Composite Material
- 7.4. Nano-Composite Material
- 7.5. Nano-Fibrous Material
- 8. Tissue Engineering Market, by Indication
- 8.1. Introduction
- 8.2. Cancer
- 8.3. Cardiology
- 8.4. Cord Blood & Cell Banking
- 8.5. Dental
- 8.6. Gastrointestinal & Gynaecology
- 8.7. Neurology
- 8.8. Organ Replacement, Transplants & Ophthalmology
- 8.9. Orthopedics, Musculoskeletal & Spine
- 8.10. Skin & Integumentary
- 8.11. Urology
- 9. Tissue Engineering Market, by Application
- 9.1. Introduction
- 9.2. Biomaterials
- 9.3. Biomedical Engineering
- 9.4. Regenerative Medicine
- 10. Americas Tissue Engineering Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Tissue Engineering Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Tissue Engineering Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 13.3.1. Agreement, Collaboration, & Partnership
- 13.3.1.1. BioMed X Extends Research Collaboration ith AbbVie On Immunology And Tissue Engineering
- 13.3.2. New Product Launch & Enhancement
- 13.3.2.1. 3D BioFibR Enters the Bioprinting and 3D Cell Culture Market with the Launch of Two CollaFibR Tissue Engineering Products
- 13.3.2.2. Essent Biologics Launches Revolutionary Human Native Tissue-Derived Type I Collagen
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. AbbVie Inc.
- 14.1.2. Aspect Biosystems Ltd.
- 14.1.3. B. Braun SE
- 14.1.4. Baxter International Inc.
- 14.1.5. Bayer AG
- 14.1.6. Becton, Dickinson and Company
- 14.1.7. Cook Group Incorporated
- 14.1.8. Corning Incorporated
- 14.1.9. CTIBiotech
- 14.1.10. Frequency Therapeutics
- 14.1.11. Gel4Med
- 14.1.12. General Electric Company
- 14.1.13. Humacyte, Inc.
- 14.1.14. Integra LifeSciences Corporation
- 14.1.15. Johnson & Johnson Services, Inc.
- 14.1.16. Medtronic PLC
- 14.1.17. Merck KGaA
- 14.1.18. Miromatrix Medical, Inc.
- 14.1.19. Modern Meadow
- 14.1.20. Novartis AG
- 14.1.21. Organogenesis Inc.
- 14.1.22. Organovo Holdings, Inc.
- 14.1.23. Pfizer Inc.
- 14.1.24. Prellis Biologics
- 14.1.25. ReproCell Inc.
- 14.1.26. Smith & Nephew PLC
- 14.1.27. Stryker Corporation
- 14.1.28. Tissue Regeneration Systems Inc.
- 14.1.29. Vericel Corporation
- 14.1.30. Zimmer Biomet Holdings, Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook